Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE